Okay, here’s a breakdown of the key information from the provided text, organized for clarity:
1. Vaccine Policy & Downplaying Science:
* A vaccine policy advisor (Kirk Milhoan) is downplaying established science “to the first order” regarding committee recommendations.
* This is important as his comments carry weight for federal vaccine policy.
* There’s also an update on a controversial U.S.-funded hepatitis B vaccine study in Guinea-Bissau, with the country’s public health minister providing information.
2. Financial Barriers to Healthcare for Doctors:
* Even doctors are facing high healthcare costs, with some having $3,000 deductibles.
* One emergency medicine doctor (Amy Caggiula) had to ask her physician to switch her medication to a cheaper, less effective, and less safe alternative due to high deductible health plans.
* This highlights a systemic issue where financial considerations impact even healthcare professionals’ treatment choices.
3. Menopause Hormone Therapy (MHT) & Weight Loss Drugs:
* A small study suggests combining menopause hormone therapy with the weight loss drug tirzepatide (like Zepbound/Mounjaro) may led to more weight loss in postmenopausal women.
* Specifically, women taking both saw 35% more overall weight loss after 15 months.
* The hormone group also had greater proportions reaching significant weight loss thresholds (20-30% of body weight).
* Both groups showed improved cardiovascular health, but the hormone group had greater reductions in diastolic blood pressure.
* The FDA has been easing access to hormone therapy (for both cisgender men and women), including removing a black box warning from menopause hormone products.
* Larger, randomized controlled trials are needed to confirm these weight loss findings.
Additional Context/Points:
* The trump management has been promoting hormone use.
* Links are provided to the original STAT News articles and the research paper in The Lancet.
Let me know if you’d like me to elaborate on any of these points or analyze the information further!
